Science

Revolutionizing delivery
across the blood-brain barrier.

 

Our Platform: TRACER

Reaching CNS targets once thought unreachable.

Voyager’s TRACER™ (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) capsid discovery platform is a broadly applicable, RNA-based screening platform that enables rapid discovery of AAV capsids with robust penetration of the blood-brain barrier and enhanced central nervous system (CNS) tropism in multiple species, including non-human primates (NHPs).

Learn More About TRACER

Non-Viral Approaches

Multiple modalities to treat neurological diseases.

The Voyager team has expertise in the discovery and development of monoclonal antibodies as well as in receptor-mediated non-viral delivery to the central nervous system.
Learn More

“I love how we all get to collaborate, even though we are on different teams.”

Gretchen Rivera, Senior Research Associate I

Our Pipeline

Transforming breakthrough science into medicines.
Learn More

Partnerships

Our allies in realizing the potential of neuro-genetic medicines

Learn More